1 / 17

Clinical Teaching Case

Clinical Teaching Case. Anthony Battad MD, FRCPC University of Manitoba. Disclosures. None. The case of Ms. LM. 55 year old aboriginal female: DM II with variable glucose control HTN, Dyslipidemia Femoral artery aneurysm (2003) – no sequelae Hypothyroidism

Download Presentation

Clinical Teaching Case

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Clinical Teaching Case Anthony Battad MD, FRCPC University of Manitoba

  2. Disclosures • None

  3. The case of Ms. LM • 55 year old aboriginal female: • DM II with variable glucose control • HTN, Dyslipidemia • Femoral artery aneurysm (2003) – no sequelae • Hypothyroidism • Meds: amlodipine, metoprolol, L-thyroxine, glyburide, metformin, pioglitazone

  4. Case… • 8 Aug – presents to Pauingassi Nursing Station with “chest heaviness” • Discharged home without specific treatment • 9 Aug – unprovoked syncope with transient LOC at home • Still has 4/10 chest heaviness • EKG done and faxed to St. Boniface Hospital

  5. EKG – Aug 9

  6. Striking Features? Deep T wave inversion Prolonged QT

  7. Case… • Patient urgently transferred to St. Boniface Hospital ER • In ER, V-fib arrest: 3-4 minutes CPR  restoration of pulse, BP, sinus rhythm • Rhythm strip is not torsade de pointes

  8. EKG – Aug 9 (ER-post arrest) 594 msec Wellen’s sign

  9. Repeat EKG – Aug 10 720 msec Wellen’s sign biphasic

  10. Case… • 10 Aug – cardiac cath: no significant stenoses • 11 Aug – echo: mild LV dilation, EF = 50 – 60% • 12 Aug – cardiac MRI: normal • 12 Aug – CT Head: nil acute • 14 Aug – EP consult • 15 Aug – ICD placed

  11. Case… • 25 Aug – discharged home • Final Diagnosis: Prolonged QT, likely congenital • note normal QT on an EKG 2 years prior • Advise given for EKG screening to family members

  12. Prolonged QT • > 450 msec men • > 470 msec women • > 500 msec “very abnormal” • QTc = QT ÷ √ R-R

  13. Prolonged QT • Congenital • Jervell & Lange-Nielson Syndrome • Romano-Ward Syndrome • Idiopathic • Acquired • Metabolic: hyperkalemia, hypocalcemia, hypomagnesemia, starvation, anorexia • Anti-arrythmics: quinidine, amiodorone, sotalol • Anti-histamines: terfenadine, astemizole • Psychotropics: TCA, haloperidol • Other meds: SSRI, methadone, protease inhibitors, levofloxacin, voriconazole

  14. Top 20 Drugs Sotalol – 4.7% Cisapride Amiodorone – 0.34 % Erythromycin – 0.18 % Ibutilide Terfenadine Quinidine – 0.45 % Clarithromycin Haloperidol – 0.14 % Fluoxetine – 0.03 % Digoxin – 0.1 % Procainamide Terodiline Fluconazole Disopyramide Bepridil Furoseamide – 0.1 % Thioridazine Flecainide Loratidine Dapro (2001), Eur Heart J

  15. Clinical Features • Palpitations • Syncope • Seizures • Sudden cardiac death – Torsade de Pointes  V-fib arrest

  16. Diagnosis • Single ECG not 100 % sensitive • “average” QT • Ambulatory monitoring • Certain features for congenital QT • EP not part of routine testing

  17. Management: ACC/AHA/ECS • Lifestyle modification • Avoid QT prolonging drugs • Avoid strenuous exercise • Beta Blockers (+/-) DDD pacing to reduce QT • Implantable Cardiac Defibrillator (ICD) • Sustained VT and/or syncopal event while on β-blocker therapy

More Related